PDB Short entry for 2Z7X HEADER IMMUNE SYSTEM 29-AUG-07 2Z7X TITLE CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TITLE 2 TRI-ACYLATED LIPOPEPTIDE CAVEAT 2Z7X NAG A 901 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 2,VARIABLE LYMPHOCYTE RECEPTOR B; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TOLL/INTERLEUKIN-1 RECEPTOR-LIKE PROTEIN 4; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: TLR2, UNP RESIDUES 27-508(HUMAN), VLRB.61, UNP COMPND 7 RESIDUES 133-199(INSHORE HAGFISH); COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: TOLL-LIKE RECEPTOR 1,VARIABLE LYMPHOCYTE RECEPTOR B; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: TOLL/INTERLEUKIN-1 RECEPTOR-LIKE PROTEIN,TIL; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: TLR1, UNP RESIDUES 25-476(HUMAN), VLRB.61, UNP COMPND 14 RESIDUES 133-199(INSHORE HAGFISH); COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: PAM3CSK4; COMPND 17 CHAIN: C; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, EPTATRETUS BURGERI; SOURCE 3 ORGANISM_COMMON: HUMAN, INSHORE HAGFISH; SOURCE 4 ORGANISM_TAXID: 9606, 7764; SOURCE 5 GENE: TLR2, TIL4, VLRB; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HI-5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PVL1393; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS, EPTATRETUS BURGERI; SOURCE 14 ORGANISM_COMMON: HUMAN, INSHORE HAGFISH; SOURCE 15 ORGANISM_TAXID: 9606, 7764; SOURCE 16 GENE: TLR1, KIAA0012, VLRB; SOURCE 17 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 18 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: HI-5; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PVL1393; SOURCE 23 MOL_ID: 3; SOURCE 24 SYNTHETIC: YES; SOURCE 25 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 26 ORGANISM_TAXID: 32630; SOURCE 27 OTHER_DETAILS: PEPTIDE SYNTHESIS KEYWDS TLR2, TLR1, PAM3CSK4, LIPOPEPTIDE, INNATE IMMUNITY, GLYCOPROTEIN, KEYWDS 2 IMMUNE RESPONSE, INFLAMMATORY RESPONSE, LEUCINE-RICH REPEAT, KEYWDS 3 MEMBRANE, RECEPTOR, TRANSMEMBRANE, CYTOPLASMIC VESICLE, IMMUNE KEYWDS 4 SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.O.LEE,M.S.JIN,S.E.KIM,J.Y.HEO REVDAT 8 07-FEB-24 2Z7X 1 COMPND SOURCE REMARK DBREF REVDAT 8 2 1 SEQADV SEQRES HET HETNAM REVDAT 8 3 1 HETSYN FORMUL LINK ATOM REVDAT 7 29-JUL-20 2Z7X 1 CAVEAT COMPND REMARK SEQADV REVDAT 7 2 1 HETNAM LINK SITE ATOM REVDAT 6 23-AUG-17 2Z7X 1 SOURCE REVDAT 5 16-AUG-17 2Z7X 1 SOURCE REMARK REVDAT 4 13-JUL-11 2Z7X 1 VERSN REVDAT 3 24-FEB-09 2Z7X 1 VERSN REVDAT 2 16-OCT-07 2Z7X 1 LINK REVDAT 1 02-OCT-07 2Z7X 0 JRNL AUTH M.S.JIN,S.E.KIM,J.Y.HEO,M.E.LEE,H.M.KIM,S.G.PAIK,H.LEE, JRNL AUTH 2 J.O.LEE JRNL TITL CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY JRNL TITL 2 BINDING OF A TRI-ACYLATED LIPOPEPTIDE JRNL REF CELL(CAMBRIDGE,MASS.) V. 130 1071 2007 JRNL REFN ISSN 0092-8674 JRNL PMID 17889651 JRNL DOI 10.1016/J.CELL.2007.09.008 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.85 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 99311 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3760 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 756 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8586 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 254 REMARK 3 SOLVENT ATOMS : 247 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.18000 REMARK 3 B22 (A**2) : 6.86000 REMARK 3 B33 (A**2) : -1.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.41 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Z7X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000027633. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 99311 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.33000 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CITRATE, 20% PEG3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 100.15150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 60.07000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 100.15150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 60.07000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 32 14.50 -67.22 REMARK 500 SER A 39 -102.35 -55.91 REMARK 500 SER A 40 101.10 -52.31 REMARK 500 SER A 42 12.72 -159.47 REMARK 500 PRO A 47 155.53 -47.11 REMARK 500 ASP A 58 88.54 -159.22 REMARK 500 LEU A 59 51.42 -112.48 REMARK 500 ASN A 61 70.11 60.38 REMARK 500 ARG A 63 89.02 -65.47 REMARK 500 THR A 65 -20.75 -149.31 REMARK 500 SER A 70 54.74 -98.00 REMARK 500 ASP A 71 0.05 -165.00 REMARK 500 LEU A 72 29.77 -159.83 REMARK 500 CYS A 75 46.57 -150.17 REMARK 500 LEU A 83 65.87 -115.56 REMARK 500 SER A 85 84.32 44.58 REMARK 500 GLU A 103 -81.74 -105.13 REMARK 500 TYR A 109 60.28 38.29 REMARK 500 ASN A 110 -163.27 -117.80 REMARK 500 PHE A 120 38.09 -96.89 REMARK 500 SER A 125 74.33 -118.07 REMARK 500 THR A 127 -34.81 -137.01 REMARK 500 PRO A 135 -9.50 -50.95 REMARK 500 GLU A 141 30.39 -84.42 REMARK 500 SER A 143 82.22 -6.23 REMARK 500 PHE A 145 88.88 54.63 REMARK 500 SER A 146 -79.33 -126.50 REMARK 500 LEU A 148 43.37 -91.02 REMARK 500 LYS A 150 -1.65 -151.76 REMARK 500 MET A 159 49.14 -81.38 REMARK 500 ASP A 160 -56.08 -140.24 REMARK 500 THR A 161 -7.49 -140.05 REMARK 500 LYS A 168 24.04 -71.69 REMARK 500 ALA A 183 45.68 -106.05 REMARK 500 ASP A 231 10.99 54.28 REMARK 500 GLU A 241 97.43 -48.66 REMARK 500 ASP A 299 -148.01 -119.35 REMARK 500 ASP A 301 -76.71 -109.08 REMARK 500 ARG A 321 51.19 -110.45 REMARK 500 ASN A 370 -158.01 -119.54 REMARK 500 ALA A 381 53.64 -104.05 REMARK 500 TRP A 386 58.26 33.03 REMARK 500 ARG A 395 -78.20 -42.96 REMARK 500 GLN A 396 78.57 -100.67 REMARK 500 ASN A 397 -146.75 -118.47 REMARK 500 LYS A 437 30.76 -92.08 REMARK 500 ILE A 484 33.08 -141.03 REMARK 500 ASN A 487 -167.22 -129.74 REMARK 500 ASP A 494 100.44 -44.79 REMARK 500 SER A 513 -163.39 -108.28 REMARK 500 REMARK 500 THIS ENTRY HAS 81 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG G 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Z80 RELATED DB: PDB REMARK 900 RELATED ID: 2Z81 RELATED DB: PDB REMARK 900 RELATED ID: 2Z82 RELATED DB: PDB DBREF 2Z7X A 27 508 UNP O60603 TLR2_HUMAN 27 508 DBREF 2Z7X A 509 575 UNP Q4G1L2 Q4G1L2_EPTBU 133 199 DBREF 2Z7X B 25 476 UNP Q15399 TLR1_HUMAN 25 476 DBREF 2Z7X B 478 544 UNP Q4G1L2 Q4G1L2_EPTBU 133 199 DBREF 2Z7X C 7 12 PDB 2Z7X 2Z7X 7 12 SEQADV 2Z7X SER B 477 UNP Q15399 LINKER SEQRES 1 A 549 SER LEU SER CYS ASP ARG ASN GLY ILE CYS LYS GLY SER SEQRES 2 A 549 SER GLY SER LEU ASN SER ILE PRO SER GLY LEU THR GLU SEQRES 3 A 549 ALA VAL LYS SER LEU ASP LEU SER ASN ASN ARG ILE THR SEQRES 4 A 549 TYR ILE SER ASN SER ASP LEU GLN ARG CYS VAL ASN LEU SEQRES 5 A 549 GLN ALA LEU VAL LEU THR SER ASN GLY ILE ASN THR ILE SEQRES 6 A 549 GLU GLU ASP SER PHE SER SER LEU GLY SER LEU GLU HIS SEQRES 7 A 549 LEU ASP LEU SER TYR ASN TYR LEU SER ASN LEU SER SER SEQRES 8 A 549 SER TRP PHE LYS PRO LEU SER SER LEU THR PHE LEU ASN SEQRES 9 A 549 LEU LEU GLY ASN PRO TYR LYS THR LEU GLY GLU THR SER SEQRES 10 A 549 LEU PHE SER HIS LEU THR LYS LEU GLN ILE LEU ARG VAL SEQRES 11 A 549 GLY ASN MET ASP THR PHE THR LYS ILE GLN ARG LYS ASP SEQRES 12 A 549 PHE ALA GLY LEU THR PHE LEU GLU GLU LEU GLU ILE ASP SEQRES 13 A 549 ALA SER ASP LEU GLN SER TYR GLU PRO LYS SER LEU LYS SEQRES 14 A 549 SER ILE GLN ASN VAL SER HIS LEU ILE LEU HIS MET LYS SEQRES 15 A 549 GLN HIS ILE LEU LEU LEU GLU ILE PHE VAL ASP VAL THR SEQRES 16 A 549 SER SER VAL GLU CYS LEU GLU LEU ARG ASP THR ASP LEU SEQRES 17 A 549 ASP THR PHE HIS PHE SER GLU LEU SER THR GLY GLU THR SEQRES 18 A 549 ASN SER LEU ILE LYS LYS PHE THR PHE ARG ASN VAL LYS SEQRES 19 A 549 ILE THR ASP GLU SER LEU PHE GLN VAL MET LYS LEU LEU SEQRES 20 A 549 ASN GLN ILE SER GLY LEU LEU GLU LEU GLU PHE ASP ASP SEQRES 21 A 549 CYS THR LEU ASN GLY VAL GLY ASN PHE ARG ALA SER ASP SEQRES 22 A 549 ASN ASP ARG VAL ILE ASP PRO GLY LYS VAL GLU THR LEU SEQRES 23 A 549 THR ILE ARG ARG LEU HIS ILE PRO ARG PHE TYR LEU PHE SEQRES 24 A 549 TYR ASP LEU SER THR LEU TYR SER LEU THR GLU ARG VAL SEQRES 25 A 549 LYS ARG ILE THR VAL GLU ASN SER LYS VAL PHE LEU VAL SEQRES 26 A 549 PRO CYS LEU LEU SER GLN HIS LEU LYS SER LEU GLU TYR SEQRES 27 A 549 LEU ASP LEU SER GLU ASN LEU MET VAL GLU GLU TYR LEU SEQRES 28 A 549 LYS ASN SER ALA CYS GLU ASP ALA TRP PRO SER LEU GLN SEQRES 29 A 549 THR LEU ILE LEU ARG GLN ASN HIS LEU ALA SER LEU GLU SEQRES 30 A 549 LYS THR GLY GLU THR LEU LEU THR LEU LYS ASN LEU THR SEQRES 31 A 549 ASN ILE ASP ILE SER LYS ASN SER PHE HIS SER MET PRO SEQRES 32 A 549 GLU THR CYS GLN TRP PRO GLU LYS MET LYS TYR LEU ASN SEQRES 33 A 549 LEU SER SER THR ARG ILE HIS SER VAL THR GLY CYS ILE SEQRES 34 A 549 PRO LYS THR LEU GLU ILE LEU ASP VAL SER ASN ASN ASN SEQRES 35 A 549 LEU ASN LEU PHE SER LEU ASN LEU PRO GLN LEU LYS GLU SEQRES 36 A 549 LEU TYR ILE SER ARG ASN LYS LEU MET THR LEU PRO ASP SEQRES 37 A 549 ALA SER LEU LEU PRO MET LEU LEU VAL LEU LYS ILE SER SEQRES 38 A 549 ARG ASN GLN LEU LYS SER VAL PRO ASP GLY ILE PHE ASP SEQRES 39 A 549 ARG LEU THR SER LEU GLN LYS ILE TRP LEU HIS THR ASN SEQRES 40 A 549 PRO TRP ASP CYS SER CYS PRO ARG ILE ASP TYR LEU SER SEQRES 41 A 549 ARG TRP LEU ASN LYS ASN SER GLN LYS GLU GLN GLY SER SEQRES 42 A 549 ALA LYS CYS SER GLY SER GLY LYS PRO VAL ARG SER ILE SEQRES 43 A 549 ILE CYS PRO SEQRES 1 B 520 SER GLU PHE LEU VAL ASP ARG SER LYS ASN GLY LEU ILE SEQRES 2 B 520 HIS VAL PRO LYS ASP LEU SER GLN LYS THR THR ILE LEU SEQRES 3 B 520 ASN ILE SER GLN ASN TYR ILE SER GLU LEU TRP THR SER SEQRES 4 B 520 ASP ILE LEU SER LEU SER LYS LEU ARG ILE LEU ILE ILE SEQRES 5 B 520 SER HIS ASN ARG ILE GLN TYR LEU ASP ILE SER VAL PHE SEQRES 6 B 520 LYS PHE ASN GLN GLU LEU GLU TYR LEU ASP LEU SER HIS SEQRES 7 B 520 ASN LYS LEU VAL LYS ILE SER CYS HIS PRO THR VAL ASN SEQRES 8 B 520 LEU LYS HIS LEU ASP LEU SER PHE ASN ALA PHE ASP ALA SEQRES 9 B 520 LEU PRO ILE CYS LYS GLU PHE GLY ASN MET SER GLN LEU SEQRES 10 B 520 LYS PHE LEU GLY LEU SER THR THR HIS LEU GLU LYS SER SEQRES 11 B 520 SER VAL LEU PRO ILE ALA HIS LEU ASN ILE SER LYS VAL SEQRES 12 B 520 LEU LEU VAL LEU GLY GLU THR TYR GLY GLU LYS GLU ASP SEQRES 13 B 520 PRO GLU GLY LEU GLN ASP PHE ASN THR GLU SER LEU HIS SEQRES 14 B 520 ILE VAL PHE PRO THR ASN LYS GLU PHE HIS PHE ILE LEU SEQRES 15 B 520 ASP VAL SER VAL LYS THR VAL ALA ASN LEU GLU LEU SER SEQRES 16 B 520 ASN ILE LYS CYS VAL LEU GLU ASP ASN LYS CYS SER TYR SEQRES 17 B 520 PHE LEU SER ILE LEU ALA LYS LEU GLN THR ASN PRO LYS SEQRES 18 B 520 LEU SER ASN LEU THR LEU ASN ASN ILE GLU THR THR TRP SEQRES 19 B 520 ASN SER PHE ILE ARG ILE LEU GLN LEU VAL TRP HIS THR SEQRES 20 B 520 THR VAL TRP TYR PHE SER ILE SER ASN VAL LYS LEU GLN SEQRES 21 B 520 GLY GLN LEU ASP PHE ARG ASP PHE ASP TYR SER GLY THR SEQRES 22 B 520 SER LEU LYS ALA LEU SER ILE HIS GLN VAL VAL SER ASP SEQRES 23 B 520 VAL PHE GLY PHE PRO GLN SER TYR ILE TYR GLU ILE PHE SEQRES 24 B 520 SER ASN MET ASN ILE LYS ASN PHE THR VAL SER GLY THR SEQRES 25 B 520 ARG MET VAL HIS MET LEU CYS PRO SER LYS ILE SER PRO SEQRES 26 B 520 PHE LEU HIS LEU ASP PHE SER ASN ASN LEU LEU THR ASP SEQRES 27 B 520 THR VAL PHE GLU ASN CYS GLY HIS LEU THR GLU LEU GLU SEQRES 28 B 520 THR LEU ILE LEU GLN MET ASN GLN LEU LYS GLU LEU SER SEQRES 29 B 520 LYS ILE ALA GLU MET THR THR GLN MET LYS SER LEU GLN SEQRES 30 B 520 GLN LEU ASP ILE SER GLN ASN SER VAL SER TYR ASP GLU SEQRES 31 B 520 LYS LYS GLY ASP CYS SER TRP THR LYS SER LEU LEU SER SEQRES 32 B 520 LEU ASN MET SER SER ASN ILE LEU THR ASP THR ILE PHE SEQRES 33 B 520 ARG CYS LEU PRO PRO ARG ILE LYS VAL LEU ASP LEU HIS SEQRES 34 B 520 SER ASN LYS ILE LYS SER ILE PRO LYS GLN VAL VAL LYS SEQRES 35 B 520 LEU GLU ALA LEU GLN GLU LEU ASN VAL ALA SER ASN GLN SEQRES 36 B 520 LEU LYS SER VAL PRO ASP GLY ILE PHE ASP ARG LEU THR SEQRES 37 B 520 SER LEU GLN LYS ILE TRP LEU HIS THR ASN PRO TRP ASP SEQRES 38 B 520 CYS SER CYS PRO ARG ILE ASP TYR LEU SER ARG TRP LEU SEQRES 39 B 520 ASN LYS ASN SER GLN LYS GLU GLN GLY SER ALA LYS CYS SEQRES 40 B 520 SER GLY SER GLY LYS PRO VAL ARG SER ILE ILE CYS PRO SEQRES 1 C 6 DCY SER LYS LYS LYS LYS MODRES 2Z7X ASN A 199 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN A 414 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN A 442 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN B 51 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN B 163 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN B 330 ASN GLYCOSYLATION SITE MODRES 2Z7X ASN B 429 ASN GLYCOSYLATION SITE HET DCY C 7 6 HET NAG D 1 14 HET NDG D 2 14 HET MAN D 3 11 HET NAG E 1 14 HET NAG E 2 14 HET MAN E 3 11 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET NAG G 1 14 HET BMA G 2 11 HET NAG A 901 14 HET NAG A 902 14 HET NAG A 903 14 HET NAG B 601 14 HET PLM C 101 17 HET Z41 C 102 39 HETNAM DCY D-CYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM PLM PALMITIC ACID HETNAM Z41 (2S)-3-HYDROXYPROPANE-1,2-DIYL DIHEXADECANOATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 DCY C3 H7 N O2 S FORMUL 4 NAG 10(C8 H15 N O6) FORMUL 4 NDG C8 H15 N O6 FORMUL 4 MAN 2(C6 H12 O6) FORMUL 6 BMA 2(C6 H12 O6) FORMUL 12 PLM C16 H32 O2 FORMUL 13 Z41 C35 H68 O5 FORMUL 14 HOH *247(H2 O) HELIX 1 1 LEU A 212 VAL A 218 1 7 HELIX 2 2 ASP A 263 ASN A 274 1 12 HELIX 3 3 ARG A 321 PHE A 325 5 5 HELIX 4 4 LEU A 328 THR A 335 5 8 HELIX 5 5 PRO A 352 LEU A 359 1 8 HELIX 6 6 VAL A 373 ALA A 381 1 9 HELIX 7 7 SER A 401 LEU A 409 1 9 HELIX 8 8 LEU A 410 LEU A 412 5 3 HELIX 9 9 ASP A 494 LEU A 498 5 5 HELIX 10 10 GLY A 517 ARG A 521 5 5 HELIX 11 11 SER A 538 LEU A 549 1 12 HELIX 12 12 TRP B 61 LEU B 66 1 6 HELIX 13 13 SER B 87 LYS B 90 5 4 HELIX 14 14 CYS B 132 MET B 138 5 7 HELIX 15 15 GLU B 152 ALA B 160 5 9 HELIX 16 16 ASP B 180 GLN B 185 5 6 HELIX 17 17 CYS B 230 LYS B 239 1 10 HELIX 18 18 LEU B 240 ASN B 243 5 4 HELIX 19 19 TRP B 258 HIS B 270 1 13 HELIX 20 20 GLN B 316 ASN B 325 1 10 HELIX 21 21 GLU B 386 THR B 395 1 10 HELIX 22 22 ASP B 413 GLY B 417 5 5 HELIX 23 23 THR B 436 CYS B 442 5 7 HELIX 24 24 PRO B 461 LEU B 467 5 7 HELIX 25 25 SER B 507 ASN B 521 1 15 HELIX 26 26 PRO B 537 ILE B 541 5 5 SHEET 1 A 2 TYR A 66 ILE A 67 0 SHEET 2 A 2 THR A 90 ILE A 91 1 O THR A 90 N ILE A 67 SHEET 1 B20 ALA A 80 VAL A 82 0 SHEET 2 B20 HIS A 104 ASP A 106 1 O ASP A 106 N LEU A 81 SHEET 3 B20 PHE A 128 LEU A 132 1 O PHE A 128 N LEU A 105 SHEET 4 B20 ILE A 153 GLY A 157 1 O ARG A 155 N LEU A 131 SHEET 5 B20 PHE A 175 ASP A 182 1 O GLU A 180 N VAL A 156 SHEET 6 B20 ASN A 199 HIS A 206 1 O ILE A 204 N ILE A 181 SHEET 7 B20 VAL A 224 ARG A 230 1 O GLU A 228 N LEU A 205 SHEET 8 B20 LYS A 253 ARG A 257 1 O ARG A 257 N LEU A 229 SHEET 9 B20 GLU A 281 ASP A 285 1 O ASP A 285 N PHE A 256 SHEET 10 B20 THR A 311 ARG A 315 1 O THR A 313 N PHE A 284 SHEET 11 B20 ARG A 340 GLU A 344 1 O GLU A 344 N ILE A 314 SHEET 12 B20 TYR A 364 ASP A 366 1 O TYR A 364 N ILE A 341 SHEET 13 B20 THR A 391 ILE A 393 1 O ILE A 393 N LEU A 365 SHEET 14 B20 ASN A 417 ASP A 419 1 O ASN A 417 N LEU A 392 SHEET 15 B20 TYR A 440 ASN A 442 1 O TYR A 440 N ILE A 418 SHEET 16 B20 ILE A 461 ASP A 463 1 O ILE A 461 N LEU A 441 SHEET 17 B20 GLU A 481 TYR A 483 1 O GLU A 481 N LEU A 462 SHEET 18 B20 VAL A 503 LYS A 505 1 O LYS A 505 N LEU A 482 SHEET 19 B20 LYS A 527 TRP A 529 1 O TRP A 529 N LEU A 504 SHEET 20 B20 GLU A 556 GLN A 557 1 O GLN A 557 N ILE A 528 SHEET 1 C 2 LYS A 164 ILE A 165 0 SHEET 2 C 2 SER A 188 TYR A 189 1 O SER A 188 N ILE A 165 SHEET 1 D 2 LYS A 260 THR A 262 0 SHEET 2 D 2 THR A 288 ASN A 290 1 O ASN A 290 N ILE A 261 SHEET 1 E 2 LYS A 561 CYS A 562 0 SHEET 2 E 2 SER A 565 PRO A 568 -1 O SER A 565 N CYS A 562 SHEET 1 F11 LEU B 28 ASP B 30 0 SHEET 2 F11 ILE B 49 ASN B 51 1 O ASN B 51 N VAL B 29 SHEET 3 F11 ILE B 73 ILE B 75 1 O ILE B 75 N LEU B 50 SHEET 4 F11 TYR B 97 ASP B 99 1 O TYR B 97 N LEU B 74 SHEET 5 F11 HIS B 118 ASP B 120 1 O HIS B 118 N LEU B 98 SHEET 6 F11 PHE B 143 THR B 148 1 O GLY B 145 N LEU B 119 SHEET 7 F11 ILE B 164 LEU B 171 1 O LEU B 168 N LEU B 146 SHEET 8 F11 THR B 189 VAL B 195 1 O VAL B 195 N LEU B 171 SHEET 9 F11 ASN B 215 LEU B 218 1 O GLU B 217 N ILE B 194 SHEET 10 F11 ASN B 248 THR B 257 1 O THR B 250 N LEU B 218 SHEET 11 F11 ILE B 221 CYS B 223 1 N ILE B 221 O GLU B 255 SHEET 1 G21 LEU B 28 ASP B 30 0 SHEET 2 G21 ILE B 49 ASN B 51 1 O ASN B 51 N VAL B 29 SHEET 3 G21 ILE B 73 ILE B 75 1 O ILE B 75 N LEU B 50 SHEET 4 G21 TYR B 97 ASP B 99 1 O TYR B 97 N LEU B 74 SHEET 5 G21 HIS B 118 ASP B 120 1 O HIS B 118 N LEU B 98 SHEET 6 G21 PHE B 143 THR B 148 1 O GLY B 145 N LEU B 119 SHEET 7 G21 ILE B 164 LEU B 171 1 O LEU B 168 N LEU B 146 SHEET 8 G21 THR B 189 VAL B 195 1 O VAL B 195 N LEU B 171 SHEET 9 G21 ASN B 215 LEU B 218 1 O GLU B 217 N ILE B 194 SHEET 10 G21 ASN B 248 THR B 257 1 O THR B 250 N LEU B 218 SHEET 11 G21 TYR B 275 GLN B 284 1 O SER B 277 N LEU B 249 SHEET 12 G21 ALA B 301 SER B 309 1 O VAL B 308 N VAL B 281 SHEET 13 G21 ASN B 330 SER B 334 1 O THR B 332 N LEU B 302 SHEET 14 G21 HIS B 352 ASP B 354 1 O ASP B 354 N VAL B 333 SHEET 15 G21 THR B 376 ILE B 378 1 O THR B 376 N LEU B 353 SHEET 16 G21 GLN B 402 ASP B 404 1 O ASP B 404 N LEU B 377 SHEET 17 G21 SER B 427 ASN B 429 1 O ASN B 429 N LEU B 403 SHEET 18 G21 VAL B 449 ASP B 451 1 O VAL B 449 N LEU B 428 SHEET 19 G21 GLU B 472 ASN B 474 1 O GLU B 472 N LEU B 450 SHEET 20 G21 LYS B 496 TRP B 498 1 O LYS B 496 N LEU B 473 SHEET 21 G21 GLU B 525 GLN B 526 1 O GLN B 526 N ILE B 497 SHEET 1 H 2 TYR B 83 ASP B 85 0 SHEET 2 H 2 LYS B 107 SER B 109 1 O SER B 109 N LEU B 84 SSBOND 1 CYS A 30 CYS A 36 1555 1555 2.03 SSBOND 2 CYS A 353 CYS A 382 1555 1555 2.05 SSBOND 3 CYS A 432 CYS A 454 1555 1555 2.05 SSBOND 4 CYS A 537 CYS A 562 1555 1555 2.03 SSBOND 5 CYS A 539 CYS A 574 1555 1555 2.03 SSBOND 6 CYS B 110 CYS B 132 1555 1555 2.04 SSBOND 7 CYS B 223 CYS B 230 1555 1555 2.03 SSBOND 8 CYS B 343 CYS B 368 1555 1555 2.05 SSBOND 9 CYS B 419 CYS B 442 1555 1555 2.03 SSBOND 10 CYS B 506 CYS B 531 1555 1555 2.03 LINK ND2 ASN A 199 C1 NAG A 901 1555 1555 1.45 LINK ND2 ASN A 414 C1 NAG A 902 1555 1555 1.45 LINK ND2 ASN A 442 C1 NAG A 903 1555 1555 1.45 LINK ND2 ASN B 51 C1 NAG D 1 1555 1555 1.46 LINK ND2 ASN B 163 C1 NAG B 601 1555 1555 1.45 LINK ND2 ASN B 330 C1 NAG E 1 1555 1555 1.46 LINK ND2 ASN B 429 C1 NAG F 1 1555 1555 1.45 LINK C DCY C 7 N SER C 8 1555 1555 1.33 LINK N DCY C 7 C1 PLM C 101 1555 1555 1.33 LINK SG DCY C 7 C35 Z41 C 102 1555 1555 1.78 LINK O4 NAG D 1 C1 NDG D 2 1555 1555 1.40 LINK O4 NDG D 2 C1 MAN D 3 1555 1555 1.40 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.39 LINK O4 NAG E 2 C1 MAN E 3 1555 1555 1.40 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.39 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.39 LINK O4 NAG G 1 C1 BMA G 2 1555 1555 1.40 CRYST1 200.303 120.140 74.120 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004992 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008324 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013492 0.00000